DBT
Dialectical Behavior Therapy
Evidence grade varies by use. See the breakdown on the entry. Read how the Atlas grades evidence.
Honest reading: published reviews describe DBT as carrying the most replicated controlled evidence of any psychotherapy designed for borderline personality disorder, which supports grade 4 for that core use. Marsha Linehan's 1991 trial and her 2006 two-year randomized controlled trial comparing DBT against treatment by community experts both reported fewer suicide attempts and less hospitalization in the DBT arm. The 2020 Cochrane review (CD012955) of psychological therapies for BPD analyzed roughly 75 trials, with DBT the single most studied approach, and concluded DBT reduced BPD severity and self-harm and improved psychosocial functioning versus usual care. Cochrane graded the certainty of those specific effects as low, meaning the direction is consistent but added data could shift the magnitude. The American Psychological Association's Society of Clinical Psychology lists DBT as having strong research support for BPD. Evidence for other indications is weaker and earlier, so the overall number is graded on the BPD and self-harm core, not the extensions.
Reference only. Not medical advice.
| Treatment | Grade | Notes |
|---|---|---|
| Borderline personality disorder severity | 4 of 5 | Most-studied psychotherapy for BPD per published reviews; multiple RCTs and Cochrane 2020 support benefit versus usual care, though Cochrane rated certainty low. |
| Self-harm and suicidal behavior reduction | 4 of 5 | Linehan 1991 and 2006 RCTs plus later meta-analyses report reduced self-harm and suicide attempts; strongest single use case. |
| Emotion dysregulation / skills training as a standalone | 3 of 5 | DBT skills training shows benefit in trials including dismantling work, but as emerging rather than guideline-settled evidence. |
| Eating disorders, substance use, adolescents | 2 of 5 | Preliminary and limited controlled data; DBT-informed programs report promise but are not established to the BPD standard. |
| PTSD as primary target | 2 of 5 | DBT-PE protocols are studied but evidence is early and trauma-focused therapies remain first-line; treat as limited. |
What can go wrong
DBT is a clinical treatment for serious conditions, not a self-directed wellness tool. It is delivered by trained mental-health clinicians and is appropriate for people experiencing self-harm, suicidality, or severe emotion dysregulation, which means it should be entered through a qualified provider, not improvised from an app or workbook alone. Skills content is generally low-risk, but using DBT materials as a substitute for crisis care is the real hazard. Anyone in crisis should contact emergency services or a crisis line directly.
This is something to take to a clinician. The Atlas can tell you what is known about dbt in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Dialectical Behavior Therapy is a structured psychotherapy that the US psychologist Marsha Linehan built in the late 1980s after finding that standard cognitive-behavioral methods alone did not hold people who were chronically suicidal and met criteria for borderline personality disorder. Her insight was that pushing only for change felt invalidating to people in acute distress, so she paired behavioral change strategies with acceptance practices she had learned in formal Zen training, naming the synthesis dialectical. A full course typically runs through weekly individual therapy, a skills group teaching mindfulness, distress tolerance, emotion regulation, and interpersonal effectiveness, phone coaching between sessions, and a consultation team that supports the therapists. Reviews describe DBT as carrying the most replicated controlled evidence of any therapy designed for BPD, with randomized trials and a 2020 Cochrane review reporting reduced self-harm and improved functioning, although Cochrane rated the certainty of those specific estimates as low. It has since been adapted for adolescents, eating behavior, and substance use, where the evidence is younger and thinner. The honest summary is a therapy that performs well for its original, hardest population and is still proving itself elsewhere.
A behavioral therapist who trained in a Zen monastery built the first treatment reported across multiple trials to cut suicide attempts in people most clinicians had given up on.
How it works
Established: DBT is a structured, manualized program. Standard outpatient DBT combines weekly individual therapy, a weekly skills-training group covering mindfulness, distress tolerance, emotion regulation, and interpersonal effectiveness, between-session phone coaching, and a therapist consultation team. What controlled trials document is that delivering this package, and the skills-training component in particular, is associated with reduced self-harm and improved functioning. Proposed and contested: the theory Linehan describes holds that chronic emotion dysregulation arises from a biologically vulnerable temperament meeting an invalidating environment, and that pairing acceptance (validation, mindfulness) with change (behavioral skills) resolves the resulting rigidity. Linehan describes this dialectical balance as the active ingredient. Whether the specific dialectical and mindfulness elements, rather than structure, therapist competence, and common therapeutic factors, drive the outcomes is not settled by the trial evidence.
What people get wrong
Often saidDBT is just CBT with a new name.
ActuallyDBT keeps CBT's change strategies but adds an equal emphasis on acceptance, validation, and Zen-derived mindfulness, plus a defined four-mode delivery structure. Linehan built it precisely because change-only CBT did not retain her patients.
Often saidYou can do DBT on your own from an app or workbook.
ActuallyStandard DBT is a clinician-delivered program for serious conditions including suicidality. Skills materials can supplement care, but using them in place of a trained provider during crisis is the documented risk, not a shortcut.
Who profits, and who pushes back
Marsha Linehan
Sells this. Has a commercial interest in a product sold as this compound, as of July 2026.
She describes DBT as a dialectical synthesis in which acceptance and change are held together, and reports in her trials that it reduced suicide attempts and hospitalization relative to comparison treatment.
Cochrane review authors (CD012955, 2020)
They conclude DBT reduced BPD severity and self-harm and improved psychosocial functioning versus usual care, while explicitly rating the certainty of those effects as low.
APA Society of Clinical Psychology
It lists DBT as having strong research support for borderline personality disorder, the highest tier in its rating scheme.
Methodological critics in BPD trial reviews
They note that many BPD psychotherapy trials, DBT included, have methodological limits and that it is not yet clear which specific DBT components, versus structure and common factors, carry the effect.
Where the research comes from
Most of the published research on this comes from one place. 95% of it is from United States. Findings that no unrelated group has reproduced are weaker than the study count makes them look.
| Place | Share of published research |
|---|---|
| United States | 95% |
| United Kingdom and Europe | 80% |
| Australia and New Zealand | 75% |
| Canada | 75% |
| East Asia | 45% |
How we got here
The acceptance half of DBT descends from contemplative practices far older than psychotherapy. Its mindfulness exercises trace to the Buddha's satipatthana teaching in the Magadha region of ancient India around the fifth century BCE, the disciplined attention to breath, body, and passing mental events. That teaching moved into China as Chan and into Japan as Zen, and it is the Japanese Zen line that reached the therapy directly. Marsha Linehan, the US psychologist who built DBT, trained under Roshi Jiyu-Kennett in the Japanese Soto Zen tradition at Shasta Abbey and under Willigis Jäger in the Sanbo Kyodan school, a twentieth-century Japanese reform lineage that blends Soto and Rinzai practice. Linehan later taught Zen herself while deliberately stripping the practices of robes, ritual, and religious framing so they could be taught as behavioral skills.
The acceptance practices DBT secularizes are roughly two and a half millennia old, originating in the Buddha's mindfulness teaching in ancient India and carried through Chinese Chan and Japanese Zen. The therapy itself is recent. Marsha Linehan began at the University of Washington in the 1980s by testing cognitive-behavioral therapy on chronically suicidal women and watching it fail to retain them. She drew on her own Zen training under Japanese-lineage teachers to add validation and mindfulness, published her first randomized trial in 1991 in Archives of General Psychiatry, and released the foundational treatment and skills-training manuals in 1993. Her 2006 trial against therapy by community experts, designed to rule out simple attention effects, again favored DBT on suicide attempts and hospitalization. In 2011 Linehan publicly disclosed that she had herself been hospitalized with severe BPD-type symptoms as a young woman, reframing DBT as a treatment built partly from lived experience. The approach has since spread internationally and been adapted well beyond its original target.
- ~5th c. BCEBuddha's satipatthana mindfulness teaching in ancient India, later carried through Chinese Chan and Japanese Zen
- Late 1980sLinehan develops DBT at the University of Washington after CBT alone fails her suicidal patients
- 1991First randomized controlled trial of DBT published in Archives of General Psychiatry
- 1993Linehan publishes the foundational DBT treatment and skills-training manuals
- 2006Two-year RCT versus therapy by community experts again favors DBT on suicide attempts and hospitalization
How it is understood
DBT openly secularizes Zen Buddhist contemplative practice into clinical skills. Linehan and the DBT literature credit the Zen lineage explicitly rather than obscuring it, which distinguishes DBT from interventions that quietly extract from living traditions. The practices were transmitted to her through formal Zen teachers and training, and she became a teacher in those lineages, so the relationship is one of acknowledged study rather than uncredited borrowing.
Where scholars disagree
DBT's clinical benefit for BPD and self-harm is well replicated, but whether its distinctive dialectical and mindfulness components, rather than its structure and the common factors of good therapy, produce that benefit is unresolved.
Linehan and DBT proponents
The specific synthesis of acceptance and change, with mindfulness and emotion-regulation skills, is the active ingredient, and skills training carries measurable independent weight.
What it rests onA 2015 component analysis by Linehan and colleagues reported that the skills-training elements contributed to outcomes, supporting a specific-ingredient account.
Methodological and common-factors critics
Much of DBT's measured advantage may reflect treatment structure, therapist competence, and nonspecific factors shared with other well-organized therapies rather than its unique theory.
What it rests onThe 2020 Cochrane review rated the certainty of DBT-specific effects as low, and reviewers note that comparison conditions and methodology limit attribution to the dialectical theory itself.
This disagreement is live. It has not settled.
At a glance
- Originator
- Marsha Linehan, psychologist, University of Washington, late 1980s
- Original target
- Chronically suicidal adults meeting criteria for borderline personality disorder
- Core structure
- Individual therapy, skills group, phone coaching, therapist consultation team
- Evidence anchor
- Linehan 1991 and 2006 RCTs; Cochrane 2020 review (CD012955), certainty rated low
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about DBT. A short entry is not a safe entry.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- What people take it for. We have not catalogued the claims made for it.
Sources
No sources recorded for this entry yet. Nothing on this page can be checked against a citation until that changes, so treat it as a summary awaiting its evidence.